Destination Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AWA
Destination Wealth Management's BMY Position: Q4 2022 in Review
Destination Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 3,136 shares — an estimated $223K sold.
Destination Wealth Management first reported a position in BMY in Q2 2015 and held it in 13 quarters. The position peaked at $756K in Q2 2015. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- Destination Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
- Destination Wealth Management sold 3,136 Bristol-Myers Squibb shares in Q4 2022, an estimated $223K.
- Destination Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 13 quarters.
- Destination Wealth Management's Bristol-Myers Squibb position peaked at $756K in Q2 2015.
- 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on Destination Wealth Management's 13F filing for Q4 2022, filed 13 Feb 2023.